Can Küçük | Health Threats | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Can Küçük — Dokuz Eylul University, Turkey

Can Küçük
Affiliation Dokuz Eylul University
Country Turkey
Scopus ID 36771222700
Documents 39
Citations 2,568
h-index 16
Subject Area Health Threats
Event Global Diseases Research Awards
ORCID 0000-0001-5540-9012

Can Küçük is a researcher affiliated with Dokuz Eylul University in Turkey whose scholarly profile is associated with health threats and related research areas. The supplied Scopus information records 39 documents, 2,568 citations, and an h-index of 16. These indicators provide a bibliometric context for describing research productivity and scholarly visibility. [1]

Abstract

Can Küçük, affiliated with Dokuz Eylul University, Turkey, is presented in this academic recognition profile in relation to research concerning health threats. The supplied Scopus profile reports 39 scholarly documents, 2,568 citations, and an h-index of 16. These bibliometric indicators provide a concise representation of publication activity and citation performance within the indexed scholarly record. The profile is considered in the context of the Innovative Research Award associated with the Global Diseases Research Awards. The recognition framework considers documented research activity, subject relevance, scholarly visibility, and research contributions addressing health-related challenges. Such work can contribute to scientific understanding, evidence development, and responses to emerging and established threats to health. [1]

Keywords

Can Küçük; Innovative Research Award; health threats; Dokuz Eylul University; Turkey; Scopus; bibliometrics; research impact; global health; infectious diseases; scientific innovation; Global Diseases Research Awards. [1]

Introduction

Health threats encompass diverse biological, environmental, epidemiological, and public health challenges that can affect individuals and populations. Research addressing these threats contributes to disease understanding, prevention, diagnosis, treatment, preparedness, and evidence-based decision-making. Innovative approaches are particularly relevant where conventional methods require improvement or where emerging threats create new scientific and public health requirements. [2]

Research Profile

The supplied Scopus information identifies Can Küçük with Author ID 36771222700 and reports 39 documents, 2,568 citations, and an h-index of 16. These values describe the indexed scholarly record associated with the specified author profile. Bibliometric records can change over time as new publications are indexed, existing records are corrected, and citation databases are updated. [1]

Research Contributions

Research addressing health threats may involve multidisciplinary approaches spanning clinical science, epidemiology, microbiology, public health, diagnostics, therapeutics, and disease prevention. Küçük’s reported scholarly record establishes measurable research activity within the stated health-threat subject area. Evaluation of individual contributions should additionally consider originality, methodology, scientific findings, collaboration, and the practical or theoretical significance of specific studies.[3]

Publications

The supplied profile records 39 documents in Scopus. This document count provides a quantitative indication of indexed scholarly output but does not independently establish the quality or significance of individual publications. A publication-level assessment would require examination of article topics, study designs, journal characteristics, authorship contributions, findings, methodological rigor, and subsequent scholarly use. [1]

Research Impact

The reported citation count of 2,568 and h-index of 16 indicate substantial citation activity within the specified Scopus record. Citation-based measures can provide useful information about scholarly visibility and subsequent use of research, although interpretation should account for publication age, disciplinary citation practices, collaboration patterns, database coverage, and differences among research fields. [3]

Award Suitability

The Innovative Research Award profile is relevant to the stated subject area of health threats and the broader research focus of the Global Diseases Research Awards. Küçük’s academic affiliation, indexed publication activity, citation record, and h-index provide measurable evidence that can be considered during recognition assessment. Final evaluation should incorporate research originality, methodological quality, scientific contribution, publication evidence, and the applicable award criteria. [4]

Conclusion

Can Küçük’s supplied academic profile documents research activity at Dokuz Eylul University in Turkey within the subject area of health threats. The reported Scopus record of 39 documents, 2,568 citations, and an h-index of 16 provides a quantitative foundation for describing indexed scholarly presence. Further publication-level review can provide additional evidence regarding innovation, scientific quality, and research contribution.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Can Küçük, Author ID 36771222700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36771222700
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/

  3. Cairns, R. A., Iqbal, J., Lemonnier, F., Kucuk, C., de Leval, L., Jais, J.-P., Parrens, M., Martin, A., Xerri, L., Brousset, P., Chan, L. C., Chan, W.-C., Gaulard, P., & Mak, T. W. (2012). IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood, 119(8), 1901–1903.
    https://doi.org/10.1182/blood-2011-11-391748

  4. Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., Kavak, P., Scuto, A., Sen, E., Gaulard, P., Staudt, L., Iqbal, J., Zhang, W., Cornish, A., Gong, Q., Yang, Q., Sun, H., d’Amore, F., Leppä, S., Liu, W., Fu, K., de Leval, L., McKeithan, T., & Chan, W. C. (2015). Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nature Communications, 6, 6025.
    https://doi.org/10.1038/ncomms7025
  5. Iqbal, J., Weisenburger, D. D., Greiner, T. C., Vose, J. M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Au, W. Y., Ko, Y.-H., Sng, I., Armitage, J. O., & Chan, W. C., & International Peripheral T-Cell Lymphoma Project. (2009). Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115(5), 1026–1036.
    https://doi.org/10.1182/blood-2009-06-227579

Muzaffer Sanci | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Muzaffer Sanci — İzmir Şehir Hastanesi, Turkey

Muzaffer Sanci
Affiliation İzmir Şehir Hastanesi
Country Turkey
Scopus ID 6508123738
Documents 165
Citations 1,526
h-index 21
Subject Area Epidemiology
Event Global Diseases Research Awards

Muzaffer Sanci is a researcher affiliated with İzmir Şehir Hastanesi in Turkey whose documented scholarly profile is associated with epidemiology. The recognition presented here concerns the Innovative Research Award within the Global Diseases Research Awards, emphasizing research activity, publication output, citation visibility, and potential relevance to contemporary disease research.[1]

Abstract

Muzaffer Sanci’s academic profile indicates sustained research activity in epidemiology, supported by 165 indexed documents, 1,526 citations, and an h-index of 21. His affiliation with İzmir Şehir Hastanesi, Turkey, places the profile within a clinical and public-health environment relevant to disease investigation. The Innovative Research Award recognizes research-oriented contributions where methodological development, evidence generation, and practical relevance may support advances in health science. The available bibliometric indicators provide a quantitative description of scholarly visibility, while interpretation of individual contributions should consider publication quality, authorship roles, research methods, and relevance to global disease challenges and population health priorities.[1]

Keywords

Muzaffer Sanci; epidemiology; innovative research; disease research; clinical research; bibliometrics; Scopus; Global Diseases Research Awards; Turkey.[1]

Introduction

Epidemiology examines the distribution, determinants, and control of health-related conditions across populations. Its methods support disease surveillance, risk assessment, prevention, and evaluation of interventions. Researchers working in clinical and population-health settings can contribute evidence that connects observed health patterns with diagnostic, therapeutic, and public-health decision-making and policy development.[2]

Research Profile

The supplied Scopus information records 165 documents, 1,526 citations, and an h-index of 21 for Muzaffer Sanci. These indicators describe indexed publication activity and citation impact, but they do not independently establish research quality. Bibliometric measures should therefore be interpreted alongside study design, originality, collaboration, and substantive contribution to knowledge and practice.[1]

Research Contributions

An epidemiology-focused research profile may encompass investigation of disease patterns, risk factors, clinical outcomes, prevention strategies, and population-level evidence. For award assessment, relevant contributions can be examined through documented publications, methodological approaches, datasets, collaborations, and the extent to which findings address clearly defined scientific or healthcare problems in practice.[2]

Publications

The supplied profile identifies 165 Scopus-indexed documents but does not provide a complete publication list or individual article metadata. Consequently, this article does not attribute specific findings to particular papers without verification. Publication assessment should use the author’s indexed record, including titles, journals, citation counts, authorship position, and persistent identifiers.[1]

Research Impact

A citation count of 1,526 and an h-index of 21 indicate measurable scholarly visibility within the supplied Scopus record. Such indicators can help contextualize research influence, while citation practices vary among disciplines. A balanced assessment should also consider clinical relevance, reproducibility, methodological rigor, collaboration, and evidence of use beyond citation counts.[1][3]

Award Suitability

The Innovative Research Award is potentially aligned with an epidemiology researcher when documented work demonstrates originality, methodological advancement, meaningful evidence generation, or practical relevance. Muzaffer Sanci’s supplied publication and citation indicators provide contextual evidence of research activity, while final award suitability should depend on independently verified scholarly contributions and eligibility criteria for recognition.[5]

Conclusion

Muzaffer Sanci’s supplied academic record presents an established epidemiology-oriented research profile, with 165 documents, 1,526 citations, and an h-index of 21. These metrics support recognition of sustained scholarly activity, but they should be considered with qualitative evidence. The Innovative Research Award assessment should therefore combine bibliometric information with verified research contributions and documented scientific relevance.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Muzaffer Sanci, Author ID 6508123738. Scopus.
    https://www.scopus.com/pages/authors/6508123738
  2. Özuyar Şimşek, G., Uzunlar, Ö., Özen, S., Çandar, T., Sancı, M., & Duman, E. D. (2026). Investigation of the effect of TNF-α levels on infertility duration and infertility characteristics in endometriosis patients presenting with infertility complaints. BMC Women’s Health, 26(1).
    https://doi.org/10.1186/s12905-026-04586-w
  3. Özen, S., Güner Özen, E., Özuyar Şimşek, G., Arzik, A. O., Karaoğlu, S., Akdemir, C., & Sanci, M. (2026). HPV persistence and CIN2+ detection in women with normal cytology and non-16/18 high-risk HPV positivity. BMC Women’s Health.
    https://doi.org/10.1186/s12905-026-04278-5
  4. Korkmaz, O., Aydemir, I., Turkoz Uluer, E., Sancı, M., Diniz, G., Sayhan, S., & İnan, S. (2026). Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: Evidence from cell lines and human tissues. Journal of Molecular Histology, 57, Article 262.
    https://doi.org/10.1007/s10735-026-10930-z
  5. Özen, S., Güner Özen, E., & Sancı, M. (2026). Preoperative imaging for nodal assessment in endometrial carcinoma: A comparative study of MRI and 18F-FDG PET/CT across risk groups. Medicina, 62(7), 1418.
    https://doi.org/10.3390/medicina62071418

 

Audrey Roulston | Public Health | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Audrey Roulston
Queen’s University Belfast

                     Audrey Roulston
Affiliation Queen’s University Belfast
Country United Kingdom
Scopus ID 55344838000
Documents 48
Citations 848
h-index 15
Subject Area Public Health
Event Global Diseases Research Awards
ORCID 0000-0002-7446-6116

Audrey Roulston is a public health researcher affiliated with Queen’s University Belfast, United Kingdom. Her research activities contribute to advancing knowledge in public health through scholarly investigations, evidence-based approaches, and interdisciplinary collaboration. Her academic profile reflects contributions through peer-reviewed publications, research outputs, and engagement with contemporary health-related challenges. [1]

Abstract

Audrey Roulston’s research profile represents academic contributions within the field of public health, focusing on evidence generation, healthcare improvement, and population-level research approaches. Her scholarly work demonstrates engagement with contemporary health issues through systematic investigation, collaboration, and dissemination of findings. Her recognition through the Innovative Research Award highlights her contribution to advancing research practices and supporting scientific development within public health disciplines. [1]

Keywords

Public Health, Health Research, Evidence-Based Research and Research Innovation

Introduction

Public health research plays a significant role in understanding health determinants, improving healthcare systems, and developing effective interventions. Researchers working in this field contribute through population studies, policy-oriented research, and evidence-based solutions. Audrey Roulston’s academic activities align with these objectives through contributions to public health scholarship and research communication. [1]

Research Profile

Audrey Roulston is associated with Queen’s University Belfast and has established a research profile within public health. According to indexed academic records, she has contributed 48 research documents with 848 citations and an h-index of 15, reflecting scholarly engagement and research visibility. [2]

Research Contributions

Her research contributions involve the development and application of public health knowledge through academic studies and collaborative research activities. Such contributions support improved understanding of healthcare challenges and provide evidence that may inform future research directions and public health strategies. [2]

Publications

Audrey Roulston’s publication record demonstrates participation in scholarly communication through peer-reviewed research outputs. Her publications contribute to discussions within public health and related research areas, supporting knowledge exchange among researchers, practitioners, and academic institutions. [3]

Research Impact

Research impact can be evaluated through publication activity, citation performance, academic collaboration, and contribution to scientific knowledge. Audrey Roulston’s citation record and h-index indicate measurable recognition within academic databases and demonstrate continued engagement with the research community. [4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful contributions, research excellence, and scientific advancement. Audrey Roulston’s academic record, public health focus, and research contributions align with the objectives of recognizing innovative approaches in global scientific research. [2]

Conclusion

Audrey Roulston represents an active contributor to public health research through scholarly publications, academic engagement, and research achievements. Her recognition with the Innovative Research Award reflects appreciation of her contributions toward advancing knowledge and supporting research excellence within the global scientific community. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Audrey Roulston, Author ID 55344838000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55344838000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Recognition.
    https://globaldiseases.org/
  3. Roulston, A., Mackle, D., Ross, J., Montgomery, L., MacDermott, D., Boyle, S., McFadden, P., & Hayes, D. (2026). Promoting staff retention in social work: Identifying the ‘push’ and the ‘pull’ factors from the perspective of newly qualified social workers. The British Journal of Social Work, 56(4), 1399–1419.
    https://doi.org/10.1093/bjsw/bcaf152

  4. McIlfatrick, S., Hasson, F., McLaughlin, D., Johnston, G., Roulston, A., Rutherford, L., Noble, H., Kelly, S., Craig, A., & Kernohan, W. G. (2013). Public awareness and attitudes toward palliative care in Northern Ireland. BMC Palliative Care, 12, Article 34. https://doi.org/10.1186/1472-684X-12-34

  5. McIlfatrick, S., Noble, H., McCorry, N. K., Roulston, A., Hasson, F., McLaughlin, D., Johnston, G., Rutherford, L., Payne, C., Kernohan, G., Kelly, S., & Craig, A. (2014). Exploring public awareness and perceptions of palliative care: A qualitative study. Palliative Medicine, 28(3), 273–280.
    https://doi.org/10.1177/0269216313502372

Zhouya Bai | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

                           Zhouya Bai
Affiliation Henan University of Science and Technology
Country China
Scopus ID 57192931889
Documents 92
Citations 1,307
h-index 18
Subject Area Epidemiology
Event Global Diseases Research Awards

Zhouya Bai

Henan University of Science and Technology, China

The Research Excellence Award article presents an academic overview of Zhouya Bai, a researcher affiliated with Henan University of Science and Technology, China. Based on publicly available scholarly metrics, the profile summarizes research productivity, publication performance, scientific influence, and contributions within epidemiology. The article follows a neutral encyclopedic style and highlights measurable academic achievements together with references to recognized scholarly databases and persistent research identifiers.[1]

Abstract

Zhouya Bai is a researcher from Henan University of Science and Technology whose academic work primarily contributes to epidemiology through peer-reviewed scientific publications and collaborative investigations. According to available Scopus metrics, the researcher has authored ninety-two indexed documents, received more than one thousand three hundred citations, and achieved an h-index of eighteen, reflecting consistent scholarly visibility and measurable research influence. These indicators demonstrate sustained participation in evidence-based research and support recognition within the Global Diseases Research Awards framework.[1]

Keywords

Research Excellence Award, Zhouya Bai, Epidemiology, Global Diseases Research Awards, Henan University of Science and Technology, Scientific Publications, Citation Impact, Scopus Author Profile.

Introduction

Epidemiology plays a central role in understanding disease occurrence, identifying public health risks, and supporting evidence-based healthcare decisions through systematic scientific investigation. Researchers working within this discipline contribute valuable knowledge that strengthens prevention strategies, improves clinical understanding, and informs policy development at regional and global levels.[2]

Research Profile

The available scholarly profile of Zhouya Bai indicates active participation in epidemiological research supported by a substantial publication record indexed within Scopus. With ninety-two indexed documents, one thousand three hundred seven citations, and an h-index of eighteen, the profile demonstrates sustained academic productivity, scientific visibility, and continued engagement with internationally recognized research standards.[1]

Research Contributions

Research contributions associated with Zhouya Bai emphasize scientific collaboration, analytical investigation, and publication of peer-reviewed studies relevant to epidemiology. Such contributions enhance scientific understanding through rigorous methodology, reproducible findings, and dissemination of evidence that supports future investigations and interdisciplinary collaboration within biomedical and public health research communities.[2]

Publications

The Scopus publication record documents ninety-two indexed scholarly works covering epidemiological topics and related scientific investigations. These publications collectively contribute to measurable citation performance and demonstrate ongoing participation in peer-reviewed academic communication, providing a reliable foundation for evaluating scientific productivity and research quality.[1]

Research Impact

Citation indicators provide quantitative evidence of scholarly influence by demonstrating how published research is referenced within the scientific literature. More than one thousand three hundred citations together with an h-index of eighteen indicate sustained academic recognition and continued relevance across related research disciplines.[3]

Award Suitability

Based on publicly available publication metrics, citation performance, and documented scholarly activity, Zhouya Bai demonstrates characteristics commonly considered during academic recognition processes. The combination of sustained publication output, measurable research impact, and established expertise in epidemiology supports suitability for consideration within the Research Excellence Award category of the Global Diseases Research Awards.[4]

Conclusion

This academic profile presents an objective overview of Zhouya Bai’s scholarly achievements using publicly available bibliometric indicators and recognized research resources. The documented publication record, citation performance, and continuing contribution to epidemiology collectively illustrate a researcher whose work reflects sustained scientific engagement and meaningful participation within the international research community.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Zhouya Bai, Author ID 57192931889. Scopus.
    https://www.scopus.com/pages/authors/57192931889
  2. Zhao, A., Han, S., Li, Q., Bai, Z., Yue, C., Li, P., Wang, L., & Luo, D. (2026). Effect of Spirulina micro-powder as a green additive on processing properties of wheat dough and bread quality. Grain & Oil Science and Technology, 9(2), 150–158.
    https://doi.org/10.1016/j.gaost.2026.03.004
  3. Bai, Z., Wan, J., Deng, W., Wang, Y., Chen, Y., Li, P., Yue, C., & Luo, D. (2026). Mechanism of ultrasound-modulated gluten-inulin interactions: Impact of inulin polymerization degree. Food Research International, 233(Part 1), Article 118963.
    https://doi.org/10.1016/j.foodres.2026.118963
  4. Wan, J., Wang, Y., Deng, W., Liu, C., Liu, M., Luo, D., Zhang, K., Gao, H., & Bai, Z. (2026). Multimodal characterization of fluorescently tagged inulin: FITC-based and fluoresceinamine-based approaches. Journal of Food Measurement and Characterization, 20, 11759–11771.
    https://doi.org/10.1007/s11694-026-04434-3
  5. Li, F., Shams, A., Han, S., Bai, Z., Yue, C., Wang, L., Guo, J., Li, P., & Luo, D. (2026). Improvement of water redistribution, rheology and microstructure of whole black wheat dough with native inulin. Journal of Cereal Science, 130, Article 104481.
    https://doi.org/10.1016/j.jcs.2026.104481

Carmen Elena Gómez | Vaccine | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Carmen Elena Gómez
National Biotechnology Center | CSIC

          Carmen Elena Gómez
Affiliation National Biotechnology Center | CSIC
Country Spain
Scopus ID 35796367700
Documents 291
Citations 10,146
h-index 47
Subject Area Vaccine
Event Global Diseases Research Awards
ORCID 0000-0002-9473-283X

Carmen Elena Gómez is a researcher affiliated with the National Biotechnology Center of the Spanish National Research Council (CSIC), Spain. Her scientific activities focus on vaccine research, biotechnology, and biomedical innovation. The Innovative Research Award recognizes distinguished contributions in developing impactful scientific approaches and advancing research knowledge within the global health landscape. Research profiles and publication records are evaluated through internationally recognized scholarly databases including Scopus.[1]

Abstract

The Innovative Research Award highlights researchers whose scientific achievements contribute to advances in biomedical sciences and healthcare innovation. Carmen Elena Gómez has established a research profile associated with vaccine development and biotechnology, supported by extensive scholarly publications, citation impact, and international scientific recognition. Her work represents contributions toward understanding and improving vaccine technologies for public health applications.[1]

Keywords

Vaccine Research, Biotechnology Innovation, Immunology, Biomedical Research and Scientific Excellence. [2]

Introduction

Vaccines represent a major area of biomedical research aimed at preventing infectious diseases and improving population health outcomes. Researchers working in vaccine science contribute through immunological studies, platform development, translational research, and evaluation of novel strategies. Carmen Elena Gómez’s academic contributions align with these objectives through research activities documented in international scientific databases.[2]

Research Profile

The researcher profile indicates affiliation with the National Biotechnology Center | CSIC in Spain. According to Scopus indexing information, the profile includes 291 documents, 10,146 citations, and an h-index of 47, reflecting a sustained research presence within the scientific literature.[1]

Research Contributions

The research contributions associated with vaccine science include investigations into vaccine platforms, immune responses, and biotechnology-based approaches. Such research supports the broader scientific objective of improving preventive healthcare strategies and strengthening preparedness against infectious diseases.[3]

Publications

The publication record of Carmen Elena Gómez includes peer-reviewed scientific outputs indexed within international research databases. These publications contribute to the understanding of vaccine technologies, molecular biology, and biomedical applications. Selected publications may include DOI-based identification for reliable scholarly access.[4]

Research Impact

Research impact is reflected through citation metrics, publication activity, and contributions to scientific knowledge. The citation count and h-index provide quantitative indicators of academic influence while recognizing that research quality is assessed through broader scholarly evaluation methods.[1]

Award Suitability

The Innovative Research Award acknowledges researchers demonstrating meaningful scientific contributions and advancement of knowledge. Carmen Elena Gómez’s documented research activity in vaccine science, supported by academic publications and measurable research indicators, aligns with the objectives of this recognition category. [2]

Conclusion

Carmen Elena Gómez represents a scientific profile associated with vaccine research and biotechnology innovation. Her academic record, publication activity, and research impact demonstrate continued engagement with internationally recognized biomedical research efforts.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Elena Gómez, Author ID 35796367700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35796367700
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Delaloye, J., Roger, T., Steiner-Tardivel, Q.-G., Le Roy, D., Knaup Reymond, M., Akira, S., Petrilli, V., Gomez, C. E., Perdiguero, B., Tschopp, J., Pantaleo, G., Esteban, M., & Calandra, T. (2009). Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathogens, 5(6), e1000480.
    https://doi.org/10.1371/journal.ppat.1000480
  4. Gómez, C. E., Perdiguero, B., & Esteban, M. (2021). Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines, 9(3), 243.
    https://doi.org/10.3390/vaccines9030243
  5. Gili, V. F., Carletti, L., Locatelli, A., Rocco, D., Finazzi, M., Ghirardini, L., Favero, I., Gomez, C., Lemaître, A., Celebrano, M., De Angelis, C., & Leo, G. (2016). Monolithic AlGaAs second-harmonic nanoantennas. Optics Express, 24(14), 15965–15975.
    https://doi.org/10.1364/OE.24.015965

Werner Mohl | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Werner Mohl
Medical University of Vienna
Werner Mohl
Affiliation Medical University of Vienna
Country Austria
Scopus ID 21641111500
Documents 113
Citations 1,315
h-index 20
Subject Area Epidemiology
Event Global Diseases Research Awards
ORCID 0000-0002-4894-0494

Werner Mohl is a researcher affiliated with the Medical University of Vienna whose scholarly activities have contributed to biomedical and epidemiological investigations through a sustained publication record. His academic profile demonstrates measurable scientific influence through peer-reviewed outputs, citation performance, and interdisciplinary engagement. The present article evaluates his research profile in the context of the Innovative Research Award associated with the Global Diseases Research Awards program.[1]

Abstract

This article presents an academic overview of Werner Mohl and evaluates the scholarly characteristics supporting consideration for the Innovative Research Award. Affiliated with the Medical University of Vienna, Mohl has established a publication portfolio comprising 113 indexed documents and 1,315 citations with an h-index of 20. His research activities demonstrate continued engagement in biomedical and epidemiological investigations while contributing to scientific literature through collaborative and peer-reviewed scholarship. Bibliometric indicators suggest sustained research productivity and measurable academic visibility. These achievements collectively provide a foundation for assessing scientific influence, knowledge dissemination, and potential recognition within international research award frameworks.[1]

Keywords

Werner Mohl; Medical University of Vienna; Epidemiology; Biomedical Research; Scientific Publications; Citation Analysis; Research Impact; Academic Recognition; Global Diseases Research Awards; Innovative Research Award.

Introduction

Recognition through scientific awards generally reflects the quality, consistency, and influence of a researcher’s contributions within a specific field. Werner Mohl’s academic profile indicates sustained participation in scientific research, publication activity, and scholarly communication. Such characteristics provide an important basis for evaluating his professional achievements within the context of international academic recognition programs and competitive award assessments.[4]

Research Profile

According to available bibliometric indicators, Werner Mohl has authored or co-authored 113 scholarly documents indexed in Scopus. These publications have accumulated 1,315 citations, resulting in an h-index of 20. Such metrics indicate a research portfolio characterized by sustained productivity and citation visibility, suggesting that a substantial number of publications have contributed to ongoing academic discourse and scientific advancement.[3]

Research Contributions

Mohl’s research contributions are associated with biomedical and epidemiological investigations that support evidence generation and scientific understanding within health-related disciplines. His scholarly work demonstrates engagement with topics relevant to disease mechanisms, clinical outcomes, and translational applications. Through collaborative publications and peer-reviewed dissemination, his research has contributed to the broader body of scientific knowledge available to researchers and healthcare professionals.[2]

Publications

The publication record associated with Werner Mohl reflects long-term engagement in scientific communication through peer-reviewed articles and collaborative research outputs. Publication activity serves as an indicator of knowledge dissemination and scholarly participation. The breadth of documented research contributions demonstrates ongoing involvement in advancing scientific understanding while supporting the exchange of evidence-based findings within the international academic community.[5]

Research Impact

Research impact may be assessed through citation performance, publication visibility, and scholarly influence. With 1,315 citations and an h-index of 20, Mohl’s academic profile demonstrates measurable engagement from the scientific community. These indicators suggest that multiple publications have been referenced by subsequent studies, reflecting continued relevance and contribution to ongoing scientific discussions and evidence development.[1]

Award Suitability

Assessment for the Innovative Research Award may consider factors including publication productivity, citation influence, research quality, and contribution to scientific advancement. Werner Mohl’s documented scholarly record demonstrates characteristics commonly associated with academic recognition. His bibliometric performance, institutional affiliation, and continued contribution to research activities collectively support consideration for distinction within the Global Diseases Research Awards framework.[1]

Conclusion

Werner Mohl’s academic profile reflects sustained scholarly productivity, measurable citation impact, and continued participation in biomedical and epidemiological research. Available indicators suggest a well-established research presence supported by peer-reviewed publications and scientific engagement. Based on the documented evidence, his professional achievements align with criteria frequently considered in international research award evaluations and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Werner Mohl, Author ID 21641111500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21641111500
  2. Global Diseases Research Awards. (n.d.). Award information and recognition framework.
    https://globaldiseases.org/
  3. Mohl, W., Spitzer, E., Mader, R. M., Wagh, V., Nguemo, F., Milasinovic, D., Jusić, A., Khazen, C., Szodorai, E., Birkenberg, B., Lubec, G., Hescheler, J., & Serruys, P. W. (2018). Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Failure, 5(5), 878–886.
    https://doi.org/10.1002/ehf2.12354
  4. Wagh, V., Nguemo, F., Kiseleva, Z., Mader, R. M., Hescheler, J., & Mohl, W. (2023). Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10-year survival. ESC Heart Failure, 10(6), 3921–3932. https://doi.org/10.1002/ehf2.14516
  5. Mohl, W., Kiseleva, Z., Jusić, A., Bruckner, M., & Mader, R. M. (2023). Signs and signals limiting myocardial damage using PICSO: A scoping review decoding paradigm shifts toward a new encounter. Frontiers in Cardiovascular Medicine, 10, 1030842. https://doi.org/10.3389/fcvm.2023.1030842

Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award

Published on by Global Diseases Research

Dr. Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award 

Lecturer | Univeristy of the Witwatersrand | South Africa

Dr. Raeesa Manjoo-Docrat is a developing scholar affiliated with the University of the Witwatersrand, Johannesburg, whose work contributes to the advancement of quantitative epidemiology and public health modelling in South Africa. Her research focuses on the development and application of spatial, age-stratified epidemiological models aimed at understanding disease transmission dynamics within heterogeneous populations. With four peer-reviewed publications and 27 citations, she has established a growing academic footprint supported by an h-index of 2, reflecting the early but significant influence of her work. Her recent open-access article in Heliyon (2025), which applies spatial modelling frameworks to the South African COVID-19 pandemic, exemplifies her commitment to integrating mathematical rigor with real-world public health challenges. Manjoo-Docrat has collaborated with multidisciplinary teams comprising epidemiologists, mathematicians, and public health scientists, enabling her to contribute to robust analytical frameworks and high-quality scientific outputs. These collaborations also highlight her ability to operate effectively within diverse research environments and to engage in evidence-based problem solving that supports both academic and policy-relevant outcomes. Her research sits at the intersection of infectious disease dynamics, health systems planning, and data-driven decision support, positioning her work within a globally relevant domain of applied epidemiology. Beyond academic metrics, her contributions have societal impact by informing approaches to epidemic preparedne  ss, guiding interventions for vulnerable demographic groups, and enhancing understanding of spatial disparities in health outcomes. Through her continued scholarship, Manjoo-Docrat aims to strengthen the integration of mathematical modelling into national and regional public health strategies, ensuring that data-informed insights contribute to improved health resilience and equitable disease control.

Profiles: Scopus | ORCID

Featured Publications

1. Manjoo-Docrat, R., Abdelatif, N., Holloway, J., Dudeni-Tlhone, N., Dresselhaus, C., Mbayise, E., … Makhanya, S. (2025). Spatial age-stratified epidemiological model with applications to South African COVID-19 pandemic. Heliyon, 11(11), e43171. https://doi.org/10.1016/j.heliyon.2025.e43171

2. Dresselhaus, C., Fabris-Rotelli, I., Manjoo-Docrat, R., Brettenny, W., Holloway, J., Thiede, R., Debba, P., & Dudeni-Tlhone, N. (2023). A spatial model with vaccinations for COVID-19 in South Africa. Spatial Statistics, 58, Article 100792. Cited by 2.

3. Manjoo-Docrat, R. (2022). A spatio-stochastic model for the spread of infectious diseases. Journal of Theoretical Biology, 533, 110943.  Cited by 16.

4. Fabris-Rotelli, I., Holloway, J., Kimmie, Z., Archibald, S., Debba, P., Manjoo-Docrat, R., … Potgieter, A. (2022). A Spatial SEIR Model for COVID-19 in South Africa. Journal of Data Science, Statistics, and Visualisation, 2(7), 14–45.  Cited by 5.

Fangfang Tao | Chikungunya Virus | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Fangfang Tao | Chikungunya Virus | Best Researcher Award 

Zhejiang Chinese Medical University | China

Prof. Dr. Fangfang Tao is a dedicated researcher at Zhejiang Chinese Medical University whose work spans integrative medicine, public health, and translational biomedical science. With a portfolio of 35 peer-reviewed publications and over 380 citations, Dr. Tao has established a growing scholarly presence supported by an h-index of 11, reflecting consistent influence and research quality. Her contributions often integrate traditional Chinese medical principles with modern clinical and epidemiological approaches, advancing evidence-based understanding of disease mechanisms, therapeutic strategies, and patient-centered health outcomes. Dr. Tao’s collaborative record is extensive, with partnerships involving more than 100 co-authors across national and international institutions, demonstrating her commitment to interdisciplinary inquiry and global scientific engagement. Her work contributes meaningfully to emerging health challenges by prioritizing rigorous methodology, culturally relevant medical insights, and innovative therapeutic frameworks. Through her research, Dr. Tao aims to bridge traditional medical knowledge with contemporary biomedical science to enhance clinical practice, inform health policy, and promote accessible, effective care. Her scholarly achievements underscore not only a strong trajectory in academic research but also a broader societal impact, as her studies support improved diagnostic approaches, better-targeted interventions, and enhanced patient well-being across diverse populations.

Profiles: Scopus | Google Scholar

Featured Publications

1. Niu, N., Zhang, J., Zhang, N., Mercado-Uribe, I., Tao, F., Han, Z., Pathak, S., … (2016). Linking genomic reorganization to tumor initiation via the giant cell cycle. Oncogenesis, 5(12), e281.
Cited by: 169

2. Tao, F., Tian, X., Ruan, S., Shen, M., & Zhang, Z. (2018). miR‐211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma. The FASEB Journal, 32(11), 6330–6343.
Cited by: 92

3. Tao, F., Tian, X., Lu, M., & Zhang, Z. (2018). A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. Journal of Genetics and Genomics, 45(3), 137–145.
Cited by: 59

4. Tian, X., Tao, F., Zhang, B., Dong, J. T., & Zhang, Z. (2018). The miR‐203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK‐3β/β-catenin signal pathway. IUBMB Life, 70(3), 224–236.
Cited by: 42

5. Jiang, X., Cui, X., Xu, H., Liu, W., Tao, F., Shao, T., Pan, X., & Zheng, B. (2019). Whole genome sequencing of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from a wastewater treatment plant in China. Frontiers in Microbiology, 10, 1797.
Cited by: 34

Monica Bhutani | Public Health | Editorial Board Member

Published on by Global Diseases Research

Dr. Monica Bhutani | Public Health | Editorial Board Member

Associate Professor | Bharati Vidyapeeth’s College of Engineering | India

Dr. Monica Bhutani is a distinguished researcher and academician at Bharati Vidyapeeth’s College of Engineering, New Delhi, India, recognized for her extensive contributions to computer science, information technology, and interdisciplinary innovations in artificial intelligence (AI), Internet of Things (IoT), and secure computing. With over 52 publications and 108 citations across 77 documents, her research demonstrates a strong commitment to advancing digital intelligence frameworks, data security architectures, and sustainable technological systems. Her recent works, including studies on AI-IoT convergence for sustainable agriculture, information dissemination networks, and secure image encryption using optimized chaotic sequences, highlight her focus on developing smart, energy-efficient, and cyber-resilient systems that address modern digital and environmental challenges. Dr. Bhutani’s scholarly collaborations with over 140 co-authors worldwide reflect her global engagement and interdisciplinary outlook, fostering impactful research networks across academia and industry. Her authorship of the book “Development and Management of Eco-Conscious IoT Medical Devices” further underscores her vision for integrating technology with environmental and healthcare sustainability. With an h-index of 6, she has consistently contributed to the global dialogue on intelligent systems design, information security, and digital transformation. Dr. Bhutani’s academic and research pursuits exemplify excellence in engineering education and innovation, bridging scientific theory with practical solutions that enhance societal well-being through technology-driven sustainability, secure communication systems, and data-driven decision-making.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1. Bhutani, M., Lall, B., & Agrawal, M. (2022). Optical wireless communications: Research challenges for MAC layer. IEEE Access, 10, 126969–126989. Cited by: 30

2. Goyal, R., Elawadhi, O., Sharma, A., Bhutani, M., & Jain, A. (2024). Cloud-connected central unit for traffic control: Interfacing sensing units and centralized control for efficient traffic management. International Journal of Information Technology, 16(2), 841–851. Cited by: 18

3. Bhutani, M., Lall, B., & Dixit, A. (2021). MAC layer performance modelling for IEEE 802.15.7 based on discrete-time Markov chain. IET Communications, 15(14), 1883–1896. Cited by: 14

4. Dr. Karthick Ganesan, D. M. B., Radhakrishnan, K., Manohar, K., & Bhutani, M. (2024). Automated dairy cow health monitoring and milking machine. US Patent 6,382,814. Cited by: 13*

5. Bhutani, M., Lall, B., & Agrawal, M. (2023). A novel energy-efficient adaptive superframe structure for OWC-based real-time bio-sensor networks. Peer-to-Peer Networking and Applications, 16(6), 3021–3031. Cited by: 10

Boon san Teoh | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Ms. Boon san Teoh | Antimicrobial Resistance | Best Researcher Award 

Senior pharmacist | Singapore General Hospital | Singapore

Dr. Boon San Teoh is a distinguished clinician and researcher affiliated with Singapore General Hospital, Singapore’s leading medical institution recognized for excellence in clinical research and healthcare innovation. His professional expertise lies in infectious diseases and antimicrobial therapy, with a particular research interest in the clinical application and comparative effectiveness of advanced antibiotics such as daptomycin and linezolid in complex hospital settings. Dr. Teoh’s recent publication, “A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital,” featured in the journal Antibiotics (2025), reflects his commitment to improving patient outcomes through evidence-based medical practice and antimicrobial stewardship. His research contributions emphasize optimizing therapeutic interventions to address antibiotic resistance and ensure safer, more effective care. Beyond his scholarly endeavors, Dr. Teoh actively collaborates with multidisciplinary teams across microbiology, pharmacology, and hospital medicine, promoting integrated approaches to clinical challenges in infectious disease management. Through his engagement in research, mentorship, and collaborative healthcare improvement initiatives, Dr. Teoh contributes significantly to the advancement of medical science in Singapore and beyond. His academic integrity, clinical insight, and dedication to patient-centered research position him as a valuable contributor to global medical innovation, enhancing understanding of infectious disease dynamics and shaping strategies for better health outcomes worldwide.

Profiles: ORCID

Featured Publication

1. Teoh, B. S., Liew, Y. X., Wang, Y., Chung, S. J., & Tan, B. H. (2025, October 28). A retrospective study on the use of Daptomycin and Linezolid in Singapore General Hospital. Antibiotics, 14(11), 1088

Dr. Boon San Teoh’s research advances antimicrobial stewardship and patient safety through evidence-based evaluation of antibiotic therapies. His work at Singapore General Hospital contributes to optimizing clinical outcomes, reducing antimicrobial resistance, and strengthening global efforts toward sustainable healthcare innovation.